Literature DB >> 25563136

Moyamoya syndrome in a patient with Noonan-like syndrome with loose anagen hair.

Jin-Ho Choi1, Moon-Yeon Oh1, Mi-Sun Yum1, Beom Hee Lee1, Gu-Hwan Kim2, Han-Wook Yoo3.   

Abstract

BACKGROUND: Noonan-like syndrome with loose anagen hair is one of the RASopathies characterized by Noonan syndrome-like features with unique ectodermal abnormalities. This syndrome is caused by mutations in the SHOC2 gene. We encountered a patient with moyamoya syndrome associated with Noonan-like syndrome with loose anagen hair presenting with transient ischemic attacks. PATIENT DESCRIPTION: A 6-year-old girl was diagnosed with Noonan-like syndrome with loose anagen hair because of profound short stature and ectodermal anomalies such as sparse and easily pluckable hair. A heterozygous mutation of c.4A>G (p.S2G) in the SHOC2 gene was identified, and recombinant human growth hormone therapy was initiated at 8 years of age. At age 10, she manifested recurrent left hemiplegia. Moreover, cerebrovascular imaging revealed occlusion or narrowing of both internal carotid arteries and both middle cerebral arteries with distal moyamoya-like vessels. She is treated with aspirin and calcium channel blocker.
CONCLUSIONS: We describe the first case of Noonan-like syndrome with loose anagen hair associated with moyamoya syndrome, although it has been reported to be associated with a few cases of other RASopathies, including Noonan, cardiofaciocutaneous, and Costello syndromes. This report emphasizes the associations between cerebrovascular anomalies and Noonan-like syndrome with loose anagen hair.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Moyamoya syndrome; Noonan syndrome; Noonan-like syndrome with loose anagen hair; SHOC2

Mesh:

Substances:

Year:  2014        PMID: 25563136     DOI: 10.1016/j.pediatrneurol.2014.11.017

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  6 in total

Review 1.  The leucine-rich repeat signaling scaffolds Shoc2 and Erbin: cellular mechanism and role in disease.

Authors:  HyeIn Jang; Payton Stevens; Tianyan Gao; Emilia Galperin
Journal:  FEBS J       Date:  2020-07-06       Impact factor: 5.542

2.  Spatial control of Shoc2-scaffold-mediated ERK1/2 signaling requires remodeling activity of the ATPase PSMC5.

Authors:  Eun Ryoung Jang; HyeIn Jang; Ping Shi; Gabriel Popa; Myoungkun Jeoung; Emilia Galperin
Journal:  J Cell Sci       Date:  2015-10-30       Impact factor: 5.285

3.  The role of USP7 in the Shoc2-ERK1/2 signaling axis and Noonan-like syndrome with loose anagen hair.

Authors:  Patricia Wilson; Lina Abdelmoti; Rebecca Norcross; Eun Ryoung Jang; Malathy Palayam; Emilia Galperin
Journal:  J Cell Sci       Date:  2021-11-05       Impact factor: 5.285

4.  Long-term efficacy of recombinant human growth hormone therapy in short-statured patients with Noonan syndrome.

Authors:  Insook Jeong; Eungu Kang; Ja Hyang Cho; Gu-Hwan Kim; Beom Hee Lee; Jin-Ho Choi; Han-Wook Yoo
Journal:  Ann Pediatr Endocrinol Metab       Date:  2016-03-31

Review 5.  A new horizon of moyamoya disease and associated health risks explored through RNF213.

Authors:  Akio Koizumi; Hatasu Kobayashi; Toshiaki Hitomi; Kouji H Harada; Toshiyuki Habu; Shohab Youssefian
Journal:  Environ Health Prev Med       Date:  2015-12-10       Impact factor: 3.674

6.  The function of Shoc2: A scaffold and beyond.

Authors:  Eun Ryoung Jang; Emilia Galperin
Journal:  Commun Integr Biol       Date:  2016-05-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.